OPTICOUGH: Instrumental and Manual Increase of Couch in Neuromuscular Patients

Sponsor
Centre d'Investigation Clinique et Technologique 805 (Other)
Overall Status
Completed
CT.gov ID
NCT01518439
Collaborator
Adep Assistance (Other)
20
1
1
18
1.1

Study Details

Study Description

Brief Summary

Inefficient cough is responsible of respiratory complications in neuromuscular patients which can lead to hospitalisation and can be life threatening. Techniques enhancing cough efficiency are successful in improving the clearance of bronchial secretions and help non invasive ventilation efficiency especially in case of acute respiratory failure. Combining mechanical exsufflation to the manual techniques of physiotherapy might enhance efficiency. Therefore the investigators want to compare cough efficiency under different techniques of instrumental and manual of cough assistance in order to determine the best combination to optimize cough flow.

Condition or Disease Intervention/Treatment Phase
  • Device: Alpha 200®
  • Device: Alpha 200® + physiotherapist
  • Device: Cough Assist®
  • Device: Cough Assist® + physiotherapist
  • Other: physiotherapist
N/A

Detailed Description

Hypothesis: Cough inefficiency in neuromuscular patients increases morbidity and mortality in case of airway infections and may lead to invasive ventilation. The use of techniques enhancing cough have been successful in improving the success of non invasive ventilation. We want to determine whether adding manual physiotherapist techniques to mechanical exsufflation improve cough efficiency and its ability to clear bronchial secretions.

Objectives: To compare cough flows obtained with different combination of the use of increased inspiratory capacity technique, mechanical insufflation-exsufflation technique and manually applied pressures techniques.

Method:open monocentric cross-over study (the patients are their own controls). Five combinations of cough increase techniques are compared Inclusion criteria: adult neuromuscular patients with a cough inefficiency at a stable state upon inclusion.

As this is a pilot study, 20 patients from the home ventilation unit of the intensive care of the Raymond Poincare teaching hospital (Garches, France) will be included during the usual follow-up of chronic respiratory failure.

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Instrumental and Manual Increase of Couch in Neuromuscular Patients: Effects of Different Techniques on the Generated Flow
Study Start Date :
Jan 1, 2012
Actual Primary Completion Date :
Jan 1, 2012
Actual Study Completion Date :
Jul 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: neuromuscular patients

neuromuscular patients with cough inefficiency in a stable respiratory state upon inclusion

Device: Alpha 200®
inspiratory capacity is increased with the use of constant pressure device: Alpha 200®

Device: Alpha 200® + physiotherapist
inspiratory capacity is increased with the use of constant pressure device (Alpha 200®) combined with the manual pressures techniques to increase cough by the physiotherapist

Device: Cough Assist®
increased inspiratory capacity and mechanical exsufflation with the use of insufflation-exsufflation device (Cough Assist®)

Device: Cough Assist® + physiotherapist
increased inspiratory capacity and mechanical exsufflation with the use of insufflation-exsufflation device (Cough Assist®) combined with the manual pressures techniques to increase cough by the physiotherapist

Other: physiotherapist
manual pressures techniques to increase cough applied by the physiotherapist

Outcome Measures

Primary Outcome Measures

  1. cough flow obtained from the combination of mechanical and manual cough assistance techniques [2 Hours]

Secondary Outcome Measures

  1. duration of efficient cough flow (above 180 l/min)under each cough assistance technique [2 Hours]

  2. respiratory comfort [2 Hours]

    evaluation with a visual analogical scale

  3. subjective evaluation of cough efficiency [2 Hours]

    evaluation with a visual analogical scale

  4. Respiratory comfort [2 Hours]

    evaluation with the Borg dyspnea scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • adult patients

  • neuromuscular disorders with a respiratory restrictive syndrome (VC < 40% and/or cough flow < 180 L/min and/or Pe max < 40 cmH2O)

  • non invasive ventilation

  • stable respiratory state > 1 month before inclusion

  • signed informed consent form

Exclusion Criteria:
  • unstable respiratory state with increased bronchial secretions

  • unstable hemodynamics

  • pneumothorax and or emphysema

  • tracheostomy

  • major bulbar involvement with swallowing dysfunction with the liquids

  • Persons under Guardianship or Trusteeship

  • Pregnant women

  • not covered by the social security system

  • refusal of study participation

Contacts and Locations

Locations

Site City State Country Postal Code
1 RAYMOND POINCARE Hospital Garches France 92380

Sponsors and Collaborators

  • Centre d'Investigation Clinique et Technologique 805
  • Adep Assistance

Investigators

  • Study Director: Frederic Lofaso, Md-PhD, University of Versailles
  • Principal Investigator: Helene Prigent, MD-PhD, University of Versailles

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre d'Investigation Clinique et Technologique 805
ClinicalTrials.gov Identifier:
NCT01518439
Other Study ID Numbers:
  • 2011-A00879-32
First Posted:
Jan 26, 2012
Last Update Posted:
Jul 19, 2013
Last Verified:
Jul 1, 2013
Keywords provided by Centre d'Investigation Clinique et Technologique 805
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 19, 2013